Toronto, Ontario--(Newsfile Corp. - November 20, 2024) - Cascada Silver Corp. (CSE: CSS) ("Cascada") is pleased to announce assay results from the Phase I reverse circulation ("RC") drill program at ...
SAN DIEGO--(BUSINESS WIRE)-- Candid Therapeutics, Inc. (“Candid”), a clinical stage biotechnology company positioned to lead the development of T-cell engagers for autoimmune diseases, appointed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback